Transcatheter Arterial Sclerosing Embolization for the Treatment of Giant Propranolol-Resistant Infantile Hemangiomas in the Parotid Region

J Vasc Interv Radiol. 2021 Feb;32(2):293-298. doi: 10.1016/j.jvir.2020.09.029. Epub 2020 Nov 18.

Abstract

Purpose: To report the effectiveness and safety of transcatheter arterial sclerosing embolization (TASE) for the treatment of parotid infantile hemangiomas that did not respond appreciably to propranolol.

Materials and methods: A total of 21 infants (12 male and 9 female) with large propranolol-resistant infantile hemangiomas in the parotid region were enrolled in this study. During TASE, the feeding arteries of the lesions were embolized using pingyangmycin-lipiodol emulsion and polyvinyl alcohol particles (300-500 μm) to reduce the blood flow rate. All children were followed up as outpatients at 2 weeks and monthly thereafter. The curative effect was evaluated at the 1- and 3-month follow-up visits.

Results: Nine lesions were located on the right side of the parotid gland, whereas 12 were located on the left side. The feeding arteries in all patients originated from branches of the external carotid artery. TASE was technically successful in all patients. The mean (± SD) maximal diameter of the hemangiomas significantly decreased from 6.50 cm ± 2.28 before treatment to 3.56 cm ± 1.84 at 1 month after TASE (P <. 05). Three months after TASE, the mean maximal diameter further significantly decreased to 1.94 cm ± 1.58 (P <. 05). During the follow-up period, 16 cases were rated as excellent and 5 as good; no recurrence or serious complications were noted. Minor side effects, such as slight pain, mild fever, and tissue swelling, were observed.

Conclusions: TASE significantly decreased the size of the parotid hemangiomas with minor side effects during a short follow-up period.

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Bleomycin / administration & dosage
  • Bleomycin / analogs & derivatives
  • Drug Resistance, Neoplasm*
  • Embolization, Therapeutic* / adverse effects
  • Ethiodized Oil / administration & dosage
  • Female
  • Hemangioma / diagnostic imaging
  • Hemangioma / pathology
  • Hemangioma / therapy*
  • Humans
  • Infant
  • Male
  • Parotid Neoplasms / diagnostic imaging
  • Parotid Neoplasms / pathology
  • Parotid Neoplasms / therapy*
  • Polyvinyl Alcohol / administration & dosage
  • Propranolol / therapeutic use*
  • Sclerosing Solutions / administration & dosage
  • Sclerotherapy* / adverse effects
  • Time Factors
  • Treatment Outcome
  • Tumor Burden

Substances

  • Antineoplastic Agents
  • Sclerosing Solutions
  • Bleomycin
  • bleomycetin
  • Ethiodized Oil
  • Polyvinyl Alcohol
  • Propranolol